Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002344890 | SCV002648272 | uncertain significance | Cardiovascular phenotype | 2021-08-05 | criteria provided, single submitter | clinical testing | The p.G19S variant (also known as c.55G>A), located in coding exon 1 of the CYP27A1 gene, results from a G to A substitution at nucleotide position 55. The glycine at codon 19 is replaced by serine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Labcorp Genetics |
RCV003096806 | SCV003486303 | likely benign | Cholestanol storage disease | 2024-09-25 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV004793781 | SCV005409009 | uncertain significance | not provided | 2024-05-09 | criteria provided, single submitter | clinical testing | PM2_moderate |